Great service
Great service as always.
Private online consultations reviewed by a UK-registered pharmacist.
We use essential cookies to operate this website. Analytics and marketing cookies are used only with your explicit consent. See our Cookies Policy and Privacy Policy.

Clinically proven. Pharmacist reviewed. Discreet UK delivery.
From £16.25 per week22.5%
maximum average weight loss with Mounjaro (SURMOUNT-1, 72 weeks)
15%
average weight loss with Wegovy (STEP-1, 68 weeks)
GPhC
registered pharmacy, every consultation reviewed by our pharmacist
24h
pharmacist review turnaround on every consultation

New, oral treatment

The same GLP-1 medicine as the injection, now a once-daily tablet. MHRA-approved for weight loss, reviewed by a UK pharmacist.
Explore the Wegovy pill
New, once-daily tablet
The once-daily tablet with no food or water rules. From £99.99 a month.
Explore FoundayoHow it works
Answer a short online questionnaire about your health. Takes a few minutes.
Your consultation is reviewed by a GPhC-registered pharmacist.
If approved, your medication is dispensed and delivered discreetly within days.
Weight Loss
GLP-1 medications like Mounjaro and Wegovy can help you lose up to 22.5% of your body weight. Start with a private online consultation, reviewed by a GPhC-registered pharmacist.


Men's Health
Effective, evidence-based treatments for hair loss and erectile dysfunction. Prescribed privately by a UK-registered pharmacist.
Weight loss estimator
Based on average clinical trial results with Mounjaro (tirzepatide) at maximum dose.
Estimated loss
22.5 kg
Target weight
77.5 kg
Based on average 22.5% body weight loss with Mounjaro 15mg (SURMOUNT-1, NEJM 2022). Individual results vary.
Clinical outcomes
These figures show the average percentage of body weight lost in published clinical trials. For a patient weighing 100kg, this represents up to 22.5kg lost with Mounjaro.
Mounjaro (tirzepatide), clinical trial data
0.0%
Patients lost an average of 22.5% of their body weight over 72 weeks (SURMOUNT-1, NEJM 2022)
Wegovy (semaglutide), clinical trial data
0.0%
Patients lost an average of 15% of their body weight over 68 weeks (STEP-1, NEJM 2021)
Results from clinical trials. Individual results may vary. Lifestyle changes are required alongside treatment.
Clinical evidence
SURMOUNT-1 · NEJM 2022 · STEP-1 · NEJM 2021

"The clinical evidence for GLP-1 medications is exceptional. Solira exists to make that evidence accessible to patients who need it."
Jimah Alsaai MPharm, Superintendent Pharmacist · GPhC 2232652
22.5%
Mounjaro max avg body weight loss
15%
Wegovy avg body weight loss
5×
more weight lost compared with diet and exercise alone
Jastreboff AM et al. NEJM 2022. Wilding JPH et al. NEJM 2021.
Start your consultationTrust
Registered pharmacy since 2024
Prescriptions reviewed within 24 hours
Royal Mail tracked delivery on every order
Plain unbranded packaging on every order
Your pharmacist

GPhC No. 2232652
Superintendent Pharmacist · Masters in Pharmacy (MPharm)
Solira
View credentialsA private, clinical service, reviewed by a GPhC-registered pharmacist
Get startedRegulated, qualified and trusted
Superintendent Pharmacist. MPharm
ZC052365